Computational studies on sirtuins from Trypanosoma cruzi: structures, conformations and interactions with phytochemicals.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 3923677)

Published in PLoS Negl Trop Dis on February 13, 2014

Authors

Lionel Sacconnay1, Melissa Angleviel1, Giuseppe Marco Randazzo1, Marcos Marçal Ferreira Queiroz1, Emerson Ferreira Queiroz1, Jean-Luc Wolfender1, Pierre-Alain Carrupt1, Alessandra Nurisso1

Author Affiliations

1: School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.

Articles cited by this

Chagas disease. Lancet (2010) 10.25

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem (1985) 6.09

Extended-connectivity fingerprints. J Chem Inf Model (2010) 5.50

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science (2007) 5.49

The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis (2008) 5.30

Accurate modeling of protein conformation by automatic segment matching. J Mol Biol (1992) 4.39

Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites. Cell (2005) 4.26

Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem (2001) 2.80

Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med (2007) 2.64

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc Natl Acad Sci U S A (2008) 2.54

Structure of the histone deacetylase SIRT2. Nat Struct Biol (2001) 2.37

Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell (2005) 2.31

The PMDB Protein Model Database. Nucleic Acids Res (2006) 1.94

Natural products as antiparasitic drugs. Parasitol Res (2003) 1.66

Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J Biol Chem (2012) 1.58

Phenolic compounds from Brazilian propolis with pharmacological activities. J Ethnopharmacol (2001) 1.55

Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother (2006) 1.48

A sirtuin in the African trypanosome is involved in both DNA repair and telomeric gene silencing but is not required for antigenic variation. Mol Microbiol (2007) 1.40

A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei. EMBO J (2003) 1.37

Diversity in the Sir2 family of protein deacetylases. J Leukoc Biol (2004) 1.33

Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases. Biochem Soc Trans (2004) 1.18

Expression of P. falciparum var genes involves exchange of the histone variant H2A.Z at the promoter. PLoS Pathog (2011) 1.11

The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition. J Med Chem (2013) 1.08

Minor cytotoxic and antibacterial compounds from the rhizomes of Amomum aculeatum. Phytochemistry (2001) 1.03

Anti-Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins. Antimicrob Agents Chemother (2004) 1.02

Natural products and Chagas' disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Nat Prod Rep (2011) 1.01

Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med (1999) 1.00

Antiparasitic therapy. Mayo Clin Proc (2011) 0.98

Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation. Gene (2005) 0.96

HDAC inhibitors in parasitic diseases. Immunol Cell Biol (2011) 0.96

Epigenetic dysregulation of virulence gene expression in severe Plasmodium falciparum malaria. J Infect Dis (2012) 0.94

Chemical constituents of Lychnophora pohlii and trypanocidal activity of crude plant extracts and of isolated compounds. Fitoterapia (2005) 0.94

Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata. Phytomedicine (2009) 0.93

Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Exp Parasitol (2007) 0.90

Antiparasitic activity of some xanthones and biflavonoids from the root bark of Garcinia livingstonei. J Nat Prod (2006) 0.89

Anti-trypanosomal activity of helenalin and some structurally related sesquiterpene lactones. Planta Med (2002) 0.88

Crystal structure analysis of human Sirt2 and its ADP-ribose complex. J Struct Biol (2013) 0.88

Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins). Biochim Biophys Acta (2010) 0.88

Anthranoid compounds with antiprotozoal activity from Vismia orientalis. Planta Med (2004) 0.86

Gaboroquinones A and B and 4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens. J Nat Prod (2002) 0.86

Trypanocidal, leishmanicidal and cytotoxic effects of anthecotulide-type linear sesquiterpene lactones from Anthemis auriculata. Phytomedicine (2009) 0.85

In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants. PLoS Negl Trop Dis (2012) 0.85

Phytochemical and antiprotozoal activity of Ocotea lancifolia. Fitoterapia (2007) 0.85

Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi. Bioorg Med Chem Lett (2004) 0.83

Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies. Immunology (2006) 0.83

Limonoid orthoacetates and antiprotozoal compounds from the roots of Pseudocedrela kotschyi. J Nat Prod (2007) 0.83

Anti-protozoal and plasmodial FabI enzyme inhibiting metabolites of Scrophularia lepidota roots. Phytochemistry (2005) 0.83

Antiprotozoal activities of heterocyclic-substituted xanthones from the marine-derived fungus Chaetomium sp. J Nat Prod (2008) 0.82

Anti-Trypanosoma cruzi activity of Pterodon pubescens seed oil: geranylgeraniol as the major bioactive component. Parasitol Res (2008) 0.82

In-vitro trypanocidal activity evaluation of crude extract and isolated compounds from Baccharis dracunculifolia D.C. (Asteraceae). J Pharm Pharmacol (2004) 0.82

Sirtuins of parasitic protozoa: in search of function(s). Mol Biochem Parasitol (2012) 0.82

Anti-Trypanosoma cruzi activity of nicotinamide. Acta Trop (2012) 0.82

Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors. Bioorg Med Chem (2009) 0.81

The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein. Immunology (2009) 0.81

Molecular docking and dynamics simulation, receptor-based hypothesis: application to identify novel sirtuin 2 inhibitors. Chem Biol Drug Des (2012) 0.80

Trypanocidal constituents in plants 2.xanthones from the stem bark of Garcinia subelliptica. Biol Pharm Bull (2003) 0.79

Activity of compounds isolated from Chilean lichens against experimental cutaneous leishmaniasis. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol (1997) 0.79

Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study. Micron (2005) 0.79

Antiprotozoal polyacetylenes from the Tanzanian medicinal plant Cussonia zimmermannii. J Nat Prod (2007) 0.79

Cissampeloflavone, a chalcone-flavone dimer from Cissampelos pareira. Phytochemistry (2003) 0.79

Phenolic analogs of the N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium A, from Ancistrocladus cochinchinensis (Ancistrocladaceae), with improved antiprotozoal activities. Phytochemistry (2010) 0.79

Comparative protein modeling and surface analysis of Leishmania sirtuin: A potential target for antileishmanial drug discovery. Bioorg Med Chem Lett (2006) 0.78

Ambigol C and 2,4-dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua. J Nat Prod (2005) 0.78

A novel antiprotozoal aminosteroid from Saracha punctata. J Nat Prod (1998) 0.78

Sirtuins as emerging anti-parasitic targets. Eur J Med Chem (2012) 0.78

Structural analysis of trypanosomal sirtuin: an insight for selective drug design. Mol Divers (2009) 0.78

Structural insights of SIR2rp3 proteins as promising biotargets to fight against Chagas disease and leishmaniasis. Mol Biosyst (2013) 0.77

Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets. Molecules (2009) 0.77

Flavonoids from Tephrosia aequilata. Phytochemistry (2002) 0.77

A diterpene from Mikania obtusata active on Trypanosoma cruzi. Planta Med (1995) 0.76

Extract screening by HPLC coupled to MS-MS, NMR, and CD: a dimeric and three monomeric naphthylisoquinoline alkaloids from Ancistrocladus griffithii. Phytochemistry (2002) 0.76

Highly selective antiplasmodial naphthylisoquinoline alkaloids from Ancistrocladus tectorius. Phytochemistry (2012) 0.76

seco-iridoids from Calycophyllum spruceanum (Rubiaceae). Phytochemistry (2003) 0.76